香港股市 已收市

雲康集團 (2325.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
14.960-0.040 (-0.27%)
收市價: 04:08PM HKT

雲康集團

No. 6 Lizhishan Road
Science City Huangpu District
Guangzhou
China
86 20 3210 6666
https://www.yunkanghealth.com

版塊Healthcare
行業Diagnostics & Research
全職員工2,476

高階主管

名稱標題支付行使價出生年份
Mr. Yong ZhangChairman & CEO5.55k1972
Mr. Yingjia LinCFO & Joint Company Sec.1979
Mr. Xubo WangExec. VP1975
Ms. Lok Yee Chan A.C.I.S., A.C.S.Joint Company Sec.1990
截止 2021年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Yunkang Group Limited operates as a medical operation service provider in China. It offers diagnostic outsourcing and diagnostic testing services, such as genetic reproduction tests and screening tests, COVID-19 and non-COVID-19 tests, diagnostic testing, pathology tests, personalized diagnostic testing, medical report consultation, hospital referral, and health management services; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papillomavirus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; and routine diagnostic tests for chronic kidney disease, blood disease, autoimmune disease, and endocrine metabolism disease. The company also provides technical support for the set-up and daily operation of the on-site diagnostic centers, which include setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, provision of equipment, smart internet of things, and logistics assistance; and medical consultation services. It offers its services through independent clinical laboratories and on-site diagnostic centers. As of December 31, 2021, the company had six laboratories located in Guangzhou, Chengdu, Shanghai, Hefei, Kunming, and Nanchang. It serves hospitals, community health clinics and other medical institutions, financial institutions, and insurance companies. Yunkang Group Limited was founded in 2008 and is based in Guangzhou, China.

公司管治

截至 無 止,雲康集團 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。